
News|Articles|February 21, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 21, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of February 19, 2022, at 2:52 PM, EDT:
43.2% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
According to the CDC as of February 19, 2022, at 2:52 PM, EDT:
• 64.7% of total US population
• 68.8% of US population aged ≥5 years
• 73.2% of US population aged ≥12 years
• 74.8% of US population aged ≥18 years
• 88.7% of US population aged ≥65 years
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Puerto Rico: 80.8%
2. Rhode Island: 80.3%
3. Vermont: 80%
4. Maine: 78.2%
5. Connecticut: 77.5%
2. Rhode Island: 80.3%
3. Vermont: 80%
4. Maine: 78.2%
5. Connecticut: 77.5%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, February 21, 2022 at 5:21 PM, EDT, there have been:
• 78 520 780 confirmed cases and
• 935 923 deaths
• 935 923 deaths
The 5 states with the highest total confirmed cases are:
1. California: 8 894 324
2. Texas: 6 581 706
3. Florida: 5 818 706
4. New York: 4 909 697
5. Illinois: 3 013 709
2. Texas: 6 581 706
3. Florida: 5 818 706
4. New York: 4 909 697
5. Illinois: 3 013 709
Deaths: California has the highest number of deaths due to COVID-19 with 84 004 reported fatalities, followed by Texas with 83 739 and Florida with 68 902.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 425 510 437 confirmed cases, 5 892 844 deaths, and 10 386 685 731 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks
2
Elinzanetant Improves Sleep Through VMS-Independent Mechanisms, According to New Pooled Analysis
3
Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms
4
Age, Not Menopause Stage, Drives Cortical Volume Reduction in Midlife Women, New Study Suggests
5